UNSPSC 51113103: Mitolactol

This classification denotes a radiosensitizing agent and epoxide compound with the molecular formula C6H12Br2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LJ2P1SIK8Y, chemically known as 1,6-dideoy-1,6-dibromo-d-mannitol but more generally known as mitolactol, which bears US NIH Compound Identifier 4208. European Medicines Agency schedules Mitolactol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09005MIG.

UNSPSC 51113103 Mitolactol, a Commodity code, represents a narrow chemical product line with minimal recent state and local procurement activity visible in the available records. Mitolactol is a specialized pharmaceutical or chemical intermediate used in formulary production, and state and local governments source it primarily through laboratory supply contracts, pharmaceutical procurement programs, or industrial chemical purchasing vehicles rather than as a standalone solicitation item. The code sees sporadic demand from state health departments, hospital systems within municipal or county networks, and specialized research or diagnostic facilities that require this compound as a reagent or ingredient in production or testing protocols.

The recent-opportunities block contains no posted solicitations under this code. Without current RFP, RFQ, IFB, or ITB activity to characterize, geographic concentration and issuing-body patterns cannot be determined from state and local records. Business development professionals evaluating entry under this code should monitor cooperative purchasing catalogs, pharmaceutical and laboratory-supply framework agreements, and state health-system procurement channels rather than watch for standalone solicitations; opportunities are more likely to surface as line items within broader chemical or pharmaceutical supply contracts than as discrete buys.